Dianthus Therapeutics (DNTH) Return on Sales (2022 - 2025)

Dianthus Therapeutics' Return on Sales history runs 4 years deep, the most recent figure standing at 0.92% for Q3 2025.

• In Q3 2025, Return on Sales fell 80.0% year-over-year to 0.92%; the TTM figure through Sep 2025 stood at 0.4% (down 27.0% YoY), while the FY2024 annual figure was 0.14%, up 2.0% from the prior year.
• Return on Sales was 0.92% for Q3 2025 at Dianthus Therapeutics, up from 1.63% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.07% in Q3 2022 to a low of 1.63% in Q2 2025.
• Historically, Return on Sales has averaged 0.32% across 4 years, with a median of 0.16% in 2024.
• The sharpest annual moves came in 2024 and 2025: Return on Sales increased 4 bps in 2024, then slumped 154 bps in 2025.
• A 4-year view of Return on Sales shows it stood at 0.09% in 2022, then sank by 184 bps to 0.25% in 2023, then climbed by 15 bps to 0.21% in 2024, then sank by 339 bps to 0.92% in 2025.
• The last three Return on Sales figures came in at 0.92% (Q3 2025), 1.63% (Q2 2025), and 0.24% (Q1 2025), per Business Quant data.